Error: Could not add to watchlist. X
+ Watchlist

CFR Pharmaceuticals SA

CFR:CI
Acquired
CFR:CI was acquired by ABT:US
CLP
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.01
Market Cap (CLP)
-
Shares Outstanding (b)
8.416
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
CFR Pharmaceuticals SA develops pharmaceuticals. The Company develops biopharmaceutical drugs for oncology, organ transplantation, dialysis, diabetes, autoimmune diseases, human immunodeficiency virus, epilepsy and respiratory diseases, injectables for anesthesia, cardiology and critical care, and oral contraconceptives, replacement hormone therapy and antiandrogens.
Address
Avenida Pedro de Valdivia 295
Providencia
Santiago
Chile
Phone
56-2-350-52-14
Show More